Wilson's Paint & Floor Coverings

Wilson's Paint and Floor Coverings located in Kaysville, Utah has been providing the best selection of paint, flooring, carpet, and window treatments for over 25 years. Our staff is knowledgeable about all of your home decor needs, and we love to help our customers make their homes look and feel great. Come in and see why we have been the premier paint, floor coverings, and carpet supplier in the Kaysville/Layton area!

HomeGuard Inspections

Thorough value-based home inspections and commercial property inspections for the Salt Lake City metropolitan area from Ogden to Spanish Fork and Heber to Tooele.

Aie Inc

Mirror Design

Mirror Design is a full service graphic design, marketing, and printing company. We help businesses and individuals create a professional and unique look and feel that sets them apart from their competition. We create a branding identity that reflects exactly who they are and what they offer. We can work with you starting at the branding, all the way to a print and digital marketing campaign. We offer DESIGN SOLUTIONS to VISUALLY COMMUNICATE what your business is all about.

Prolexys Pharmaceuticals

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need. Lead programs include a) solid tumor oncology program with a small molecule clinical candidate with selective anti-tumor activity, b) the colon cancer program with novel small molecule compounds targeting the beta-catenin signaling cascade and c) HSP20 antagonists, identified as protein interaction inhibitors from targets validated in asthma and vasorelaxation. Prolexys' ability to identify and validate novel therapeutic targets is driven by its technological leadership in the field of proteomics and the application of proteomics technologies to its own, and its partners, drug discovery programs. Prolexys has developed two key technologies, a high throughput yeast 2 hybrid system called HyNet™, and a mass spectrometry-based protein science technology called HySpec™, that complement one another and provide a powerful approach for identifying novel molecular targets relevant to the treatment of human disease. In addition, Prolexys has developed HyScreen, to validate the therapeutic utility of these novel targets as well as in house high-throughput screening, in vivo pharmacology, medicinal chemistry, and drug development capabilities. Prolexys was formed in 2001 with investments from Myriad Genetics, Inc., Hitachi Ltd., Friedli Corporate Finance, A.G., and Oracle Corporation. The company is privately held and located in Salt Lake City, Utah.